ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near San Francisco, CA, USA:

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

This is a phase II study using risk and response-adapted therapy for low, intermediate and high risk classical Hodgkin lymphoma. Chemotherap...

Enrolling
Hodgkin Lymphoma
Drug: Etoposide
Drug: DTIC

Phase 2

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital

Palo Alto, California, United States and 7 other locations

Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Rituximab
Drug: Lenalidomide

Phase 3

Celgene
Celgene

Berkeley, California, United States and 125 other locations

This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...

Active, not recruiting
Relapsed/Refractory Peripheral T-Cell Lymphoma
Adult T Cell Leukemia/Lymphoma
Drug: Valemetostat Tosylate

Phase 2

Daiichi Sankyo
Daiichi Sankyo

San Francisco, California, United States and 59 other locations

Lenalidomide has been shown to have single agent activity in indolent Non-Hodgkin's Lymphoma. It is approved for the treatment of multiple m...

Active, not recruiting
Non Hodgkin's Lymphoma
Drug: Rituximab
Drug: Lenalidomide

Phase 2

University of California (UC) Davis
University of California (UC) Davis

Santa Rosa, California, United States and 1 other location

This is a First-in-Human Phase I trial of ATG-101 in Patients with Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas....

Enrolling
Mature B-cell Non-Hodgkin Lymphoma
Advanced Solid Tumor
Drug: ATG-101

Phase 1

Antengene
Antengene

San Francisco, California, United States and 7 other locations

017 works in treating patients with non-Hodgkin's lymphoma whose disease has come back or has not responded to treatment....

Active, not recruiting
Follicular Lymphoma
Mantle-cell Lymphoma
Biological: JCAR017 (lisocabtagene maraleucel) single-dose schedule
Biological: JCAR017 (lisocabtagene maraleucel) 2-dose schedule

Phase 1

Juno Therapeutics

San Francisco, California, United States and 13 other locations

in patients with relapsed central nervous system (CNS) lymphoma. This is the first study to examine a naked anti-CD19 monoclonal antibody in...

Enrolling
CNS Lymphoma
Primary Central Nervous System Lymphoma
Drug: Tafasitamab
Drug: Lenalidomide

Phase 1, Phase 2

James Rubenstein

San Francisco, California, United States

is evaluating a novel drug called CUDC-907 as a possible treatment for resistant (refractory) pediatric solid tumors (including neuroblastoma), lymphoma...

Active, not recruiting
Lymphoma
Solid Tumor
Drug: CUDC-907

Phase 1

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

San Francisco, California, United States and 3 other locations

A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...

Enrolling
EBV Associated Lymphoma
EBV Related Non-Hodgkin's Lymphoma
Drug: Nanatinostat in combination with valganciclovir

Phase 2

Viracta Therapeutics

San Francisco, California, United States and 93 other locations

A Phase 1/2 Study of bbT369, a dual targeting CAR T cell drug product with a gene edit, in Relapsed and/or Refractory B cell Non-Hodgkin's Lymphoma...

Enrolling
Diffuse Large B Cell Lymphoma (DLBCL)
Biological: bbT369

Phase 1, Phase 2

2seventy bio

Stanford, California, United States and 3 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems